BIO

Bio-Rad Laboratories, Inc.

Healthcare›Medical - Devices|New York Stock Exchange|US

Price

$279.99

Market Cap

$7.56B

Beta

1.16

P/E

10.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.65%

EPS Growth (YoY)+142.91%

Revenue CAGR 3Y-2.68%

P/E Ratio10.0

PEG Ratio0.07

FCF Yield+4.96%

Debt / Equity0.21

Interest Coverage4.7x

No credit card required

Already have an account? Sign in to view the full analysis for BIO.